Effect of Genistein, a Soy Isof lavone, on Whole Body Insulin Sensitivity and Renal Damage Induced by a High-Fructose Diet

REFERENCES

• Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes. 2001; 37: 1595–1607
   Google Scholar
• Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002; 76: 911–922
   PubMed Web of Science ®Google Scholar
• Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987; 10: 512–516
   PubMed Web of Science ®Google Scholar
• Rajasekar P, Viswanathan P, Anuradha CV. Renoprotective action of L-carnitine in fructose-induced metabolic syndrome. Diabetes Obesity and Metabolism. 2007; 10: 171–180
   Google Scholar
• Sa´nchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobel M, Nepomuceno T. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol. 2007; 292: F423–F429
   PubMed Web of Science ®Google Scholar
• Azadbakht L, Shakerhosseini R, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr. 2003; 57: 1292–1294
   PubMed Web of Science ®Google Scholar
• Vedavanam K, Srijayanta S, O'Reilly J, Ranam A, Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soybean phytochemical extract (SPE). Phytother Res. 1999; 13: 601–608
   PubMed Web of Science ®Google Scholar
• Lee DS, Lee SH. Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. FEBS Lett. 2001; 501: 84–86
   PubMed Web of Science ®Google Scholar
• Li Y, Ellis KL, Ali S, El-Rayes BF, Nedeljkovic-Kurepa A, Kucuk O, Philip PA, Sarkar FH. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappa B in B×PC-3 pancreatic cancer cell line. Pancreas. 2004; 28(4)e90–e95
   Google Scholar
• Park SA, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 2006; 79: 1207–1213
   PubMed Web of Science ®Google Scholar
• Kojima T, Uesugi T, Toda T, Miura Y, Yagasaki K. Hypolipidemic action of the soybean isoflavones genistein and genistin in glomerulonephritic rats. Lipids. 2002; 37(3)261–265
   Google Scholar
• Gutt M, Davis CL, Spitzer SB. Validation of the insulin sensitivity index (ISI0,120): Comparison with other measures. Diabetes Res Clin Pract. 2000; 47: 177–184
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS. Homoeostasis model assessment: insulin and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann D, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000; 85: 2402–1240
   PubMed Web of Science ®Google Scholar
• Niehaus WG, Samuelson B. Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1986; 6: 126–130
   Google Scholar
• Ellman GL. Tissue sulfphydryl groups. Arch Biochem Bio Phys. 1959; 82: 70–77
   PubMedGoogle Scholar
• Ali BH, Mousa HM. Effect of dimethylsulfoxide on gentamicin-induced nephrotoxicity in rats. Human Exp Toxicology. 2001; 20(4)199–203
   Google Scholar
• Fabris B, Candido R, Armini L, Fischetti F, Calci M, Bardelli M. Control of glomerular hyper filtration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats. J Hypertens. 1999; 17(12)1925–1931
   Google Scholar
• Yamada H, Hishida A, Kumagai H, Nishi S. Effects of age, renal diseases and diabetes mellitus on renal size reduction accompanied by the decrease on renal function. Nippon Jinzo Gakkai Shi. 1992; 34(10)1071–1075
   Google Scholar
• Bwititi P, Musabayane CT, Nhachi CFB. Effects of Opuntia megacantha on blood glucose and kidney function in streptozotocin diabetic rats. J Ethnopharmacology. 2000; 69: 247–252
   PubMed Web of Science ®Google Scholar
• Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Nepomuceno T, Rodriguez-Iturbe B, et al. Mild hyperurcemia induces severe cortical vasoconstriction and perpetuates glomerular hypertension in normal rats and in experimental chronic renal failure. Kidney Int. 2005; 67: 237–247
   PubMed Web of Science ®Google Scholar
• Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005; 67: 1739–1742
   PubMed Web of Science ®Google Scholar
• Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001; 38: 1101–1106
   PubMed Web of Science ®Google Scholar
• Kang D-H, Park SK, Lee IK, Johnson RJ. Uric acid induced C-reactive protein (CRP) expression: Implication on cell proliferation and nitric oxide production in human vascular cells. J Am Soc Nephrol. 2005; 67: 1739–1742
   Google Scholar
• Hallfrisch J. Metabolic effects of dietary fructose. FASEB J. 1990; 4: 2652–2660
   PubMed Web of Science ®Google Scholar
• Cosenzi A, Berobich E, Bonavita M, Gris F, Odoni G, Bellini G. Role of nitric oxide in the early renal changes induced by high-fructose diet in rats. Kidney Blood Press Res. 2002; 25(6)363–369
   Google Scholar
• Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Fructose- induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol. 2005; 1: 80–86
   PubMedGoogle Scholar
• Hoffman RS, Martino JA, Wahl G, Arky RA. Fasting and refeeding. Antinatriuretic effect of oral and intravenous carbohydrates and its relationship to potassium excretion. Metabolism. 1971; 20: 1065–1073
   Google Scholar
• Pedraza-Chaverri J, Barrera D, Hernandez-Pando R. Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci. 2007; 74: 987–999
   Google Scholar
• Lee JS. Effects of soy protein and genistein blood glucose, antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006; 79(16)1578–1584
   PubMed Web of Science ®Google Scholar
• Choi C, Cho H, Park J, Cho C, Song Y. Suppressive effects of genistein on oxidative stress and NFκB activation in RAW 264.7 macrophages. Biosci Biotechol Biochem. 2003; 67(9)1916–1922
   PubMed Web of Science ®Google Scholar
• Wu H-J, Chan W-H. Genistein protects methylglyoxal-induced oxidative DNA damage and cell injury in human mononuclear cells. Toxicology in Vitro. 2007; 21: 335–342
   PubMed Web of Science ®Google Scholar
• Mahn K, Borras C, Knock GA, Taylor P, Khan IY, Sugden D. Dietary soy isoflavone-induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J. 2005; 10: 1–8
   Google Scholar
• Echiffrin EL. Enthelin: Role in experimental hypertension. Cardiovasc. Pharmacol. 2002; 35(4)533–535
   Google Scholar
• Sowers JR. Insulin resistance and hypertension. Am J Phyhsiol Heart Circ Physiol. 2004; 286: H1597–H1602
   PubMed Web of Science ®Google Scholar
• Araki E, Murakami T, Shirotani T. A cluster of four SPI binding sites required for efficient expression of the human insulin receptor gene. J Biol Chemistry. 1991; 266(6)3944–3948
   Google Scholar